Possible Impact of Merck Acqusition of Cubist on the Trius CVRMonday, December 8, 2014 · 5:19 pm |
|
Cubist Pharmaceuticals: An Overview Based on a Recent Company Presentation (CBST, No Opinion)Monday, June 30, 2014 · 2:07 pm |
|
Trius Therapeutics to be Acquired by Cubist (TSRX: $13.66)Wednesday, July 31, 2013 · 1:48 pm |
|
There are 3 reports on file. |